Cargando…

Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells

The secondary analyses for correlates of risk of infection in the RV144 HIV-1 vaccine trial implicated vaccine-induced antibody-dependent cellular cytotoxicity (ADCC) responses in the observed protection, highlighting the importance of assessing such responses in ongoing and future HIV-1 vaccine tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fisher, Leigh, Zinter, Melissa, Stanfield-Oakley, Sherry, Carpp, Lindsay N., Edwards, R. Whitney, Denny, Thomas, Moodie, Zoe, Laher, Fatima, Bekker, Linda-Gail, McElrath, M. Juliana, Gilbert, Peter B., Corey, Lawrence, Tomaras, Georgia, Pollara, Justin, Ferrari, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890556/ https://www.ncbi.nlm.nih.gov/pubmed/31827470 http://dx.doi.org/10.3389/fimmu.2019.02741

Ejemplares similares

Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV
por: Wang, Shixia, et al.
Publicado: (2022)

Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies
por: Mielke, Dieter, et al.
Publicado: (2022)

Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials
por: Fischinger, Stephanie, et al.
Publicado: (2021)

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens
por: Shen, Xiaoying, et al.
Publicado: (2020)

Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell‐mediated cytotoxicity assay
por: Pollara, Justin, et al.
Publicado: (2018)

Development of flow cytometry‐based assays to assess the ability of antibodies to bind to SARS‐CoV‐2‐infected and spike‐transfected cells and mediate NK cell degranulation
por: Mielke, Dieter, et al.
Publicado: (2022)

Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
por: Pierre, Camille N., et al.
Publicado: (2023)

Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans
por: Zhao, Lue Ping, et al.
Publicado: (2020)

Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models
por: Pollara, Justin, et al.
Publicado: (2019)

Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)
por: Peiperl, Laurence, et al.
Publicado: (2010)

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk
por: Andersen-Nissen, Erica, et al.
Publicado: (2021)

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials
por: Moodie, Zoe, et al.
Publicado: (2020)

Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies
por: Vaine, Michael, et al.
Publicado: (2010)

Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans
por: Xu, Shiwei, et al.
Publicado: (2022)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
por: Mielke, Dieter, et al.
Publicado: (2019)

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
por: Ditse, Zanele, et al.
Publicado: (2020)

A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques
por: Jones, Andrew T., et al.
Publicado: (2018)

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
por: Spearman, P, et al.
Publicado: (2012)

Editorial: Effector functions of therapeutic antibodies
por: Boross, Peter, et al.
Publicado: (2023)

Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
por: Bernard, Nicole F., et al.
Publicado: (2022)

P17-25. A model for coverage of T-cell HIV vaccines: where are we and where do we need to be?
por: Self, S, et al.
Publicado: (2009)

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial
por: Mpofu, Rephaim, et al.
Publicado: (2021)

Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection
por: Astronomo, Rena D., et al.
Publicado: (2016)

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-γ Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study
por: Huang, Yunda, et al.
Publicado: (2014)

P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection
por: Spies, G, et al.
Publicado: (2009)

Macrophages are critical effectors of antibody therapies for cancer
por: Weiskopf, Kipp, et al.
Publicado: (2015)

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
por: Stamatatos, Leonidas, et al.
Publicado: (2021)

Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response
por: Williams, LaTonya D., et al.
Publicado: (2023)

Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
por: Tay, Matthew Zirui, et al.
Publicado: (2019)

Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment
por: Motais, Benjamin, et al.
Publicado: (2021)

Vaccinating for natural killer cell effector functions
por: Wagstaffe, Helen R, et al.
Publicado: (2018)

A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
por: Stamatatos, Leonidas, et al.
Publicado: (2021)

RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses
por: Bradley, Todd, et al.
Publicado: (2018)

Emergent Electroweak Gravity
por: McElrath, Bob
Publicado: (2008)

Laboratory tests for the cosmic neutrino background using beta-decaying nuclei
por: McElrath, Bob
Publicado: (2009)

On The Origin of Neutrino Mass and Mixing in the Standard Model
por: McElrath, Bob
Publicado: (2009)

Use of adenovirus type-5 vectored vaccines: a cautionary tale
por: Buchbinder, Susan P, et al.
Publicado: (2020)

COVID-19 vaccination and HIV-1 acquisition – Authors’ reply
por: Buchbinder, Susan P, et al.
Publicado: (2022)

Developing a quantitative model of antibody effector function
por: Boesch, AW, et al.
Publicado: (2012)

Vector induced skewing of antibody Fc-effector functions
por: Chung, A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g1qfrd663v3sfif6u0t8b3t9q1